Claims

KOKU improves lower-limb function, concerns about falling and health-related quality of life, but not mood, physical activity, fatigue or fall rate

Claim · All claims
Evidence · 1 study (2 entries) · causal r2–r3 · q3 · i0–i2
Currency · newest study 2026 · 1 of 2 entries checked against their sources (automated) · not reviewed by a person

Subclaims

Reading the evidence codes

q is the design tier, i the impact, n the sample, and the kind with its r the rigour judged within that kind: what each code means.

This claim: no standardized effect is recorded in observations/ for it yet, so no benchmark reading is possible.

q3 i2 Participants receiving KOKU had improved (lower) 5-STS time at 12 weeks (mean difference −6.85; 95% CI −10.47, −3.24) and less concern about falling (Short FES-I mean difference −3.11 at 12 weeks) than controls. → French Chloe 2026 q3 i? There was no statistically significant difference between groups in fall rate over 24-week follow-up (IRR 0.84), nor in EQ-VAS, PASE, fatigue, depression risk or FRAT fall risk. → French Chloe 2026 (2)

Evidence

French Chloe 2026

French Chloe, Parchment Amelia, Odebiyi Bolanle, Shi Chunhu, Bashir Saima, Dowding Dawn, Kislov Roman, Thompson Alexander, Skelton Dawn A, Clarke Margaret, Sylvestre Garcia Yvonne, Ahmed Saima S, Todd Chris J, Bower Peter, Stanmore Emma. (2026). Effectiveness and cost-effectiveness of the Keep-On-Keep-Up digital falls prevention programme in community-dwelling older adults: results of a randomised controlled trial. Age and Ageing. https://doi.org/10.1093/ageing/afag291

q3 · i2 · causal · r3

Secondary outcomes of the same MMRM analysis of the randomised trial at 12 weeks. KOKU participants showed "improved (lower) 5-STS time (seconds)" and reduced Short FES-I scores; EQ-5D-5L also differed significantly at both timepoints.

"Participants who received the KOKU intervention had less concern about falling (assessed using short FES-I) at both 6- and 12-weeks compared to participants in the control group (mean difference: −3.11 at 12 weeks; 95% CI: −4.37, 2.66; Table 2). In addition, participants receiving the KOKU intervention had improved (lower) 5-STS time (seconds) at 12-weeks compared to participants in the control group (mean difference: −6.85; 95% CI: −10.47, −3.24)."

French Chloe 2026 (2)

French Chloe, Parchment Amelia, Odebiyi Bolanle, Shi Chunhu, Bashir Saima, Dowding Dawn, Kislov Roman, Thompson Alexander, Skelton Dawn A, Clarke Margaret, Sylvestre Garcia Yvonne, Ahmed Saima S, Todd Chris J, Bower Peter, Stanmore Emma. (2026). Effectiveness and cost-effectiveness of the Keep-On-Keep-Up digital falls prevention programme in community-dwelling older adults: results of a randomised controlled trial. Age and Ageing. https://doi.org/10.1093/ageing/afag291

q3 · i0 · causal · r2

Fall counts from self-reported fall calendars over 24 weeks compared by Poisson regression adjusting for baseline values. The trial also found no significant effect on depression risk (GDS), FRAT fall risk, EQ-VAS, PASE or fatigue at 6 or 12 weeks; equivalence was not tested.

"A total of 73 falls (52% control; 48% KOKU) were self-reported during the 24-week follow-up (IRR: 0.84, 95% CI: −0.63, 0.28) showing no significant difference in number of falls between groups."

Discussion

Learner Variables

Page metadata
Field Value
type claim
id koku-secondary-outcomes-mixed
title KOKU improves lower-limb function, concerns about falling and health-related quality of life, but not mood, physical activity, fatigue or fall rate
description KOKU improves lower-limb function, concerns about falling and health-related quality of life, but not mood, physical activity, fatigue or fall rate
status review
evidence_strength moderate
newest_evidence 2026
generated by process:wiki-ingest on 2026-09-26
trust unverified — no one has confirmed this page's content
sources 2 — french-chloe-2026, french-chloe-2026-2

Frontmatter is the page's machine-readable record — see the Schema & Guide.